05/24/2026
Current Ebola Update 🌍🩺
Recent reports from the DRC and Uganda continue highlighting the seriousness of the Bundibugyo Ebola outbreak:
• 746 suspected cases
• 83 confirmed cases
• 176 suspected deaths
• 9 confirmed deaths
WHO classifies the risk as very high nationally in affected DRC regions, high regionally in Africa, and presently low globally.
The outbreak has expanded across multiple health zones and provinces, prompting intensified surveillance, isolation, PCR testing, traveler screening, contact tracing, PPE protection, and hospital preparedness.
Reports also indicate that a second Ebola treatment center was burned during unrest, and 18 individuals left one treatment center, raising concern around transmission monitoring and contact tracing.
This Bundibugyo strain currently has no approved targeted vaccine or monoclonal antibody therapy. Vaccine development, surveillance, and regional containment continue accelerating.
Ebola spreads through direct contact with infected blood, bodily fluids, contaminated materials, or infected tissues. It is not considered a routine airborne virus.
Treatment focuses on intensive supportive care: IV fluids, electrolytes, oxygen, blood pressure support, nutrition, ICU care, and organ support when needed.
The U.S. and other countries continue preparedness through enhanced airport screening, designated entry airports, CDC quarantine stations, traveler monitoring, hospital readiness, rapid isolation, and laboratory preparedness.
Rapid response, transparency, healthcare infrastructure, research, community education, and international cooperation remain essential.
Deep gratitude to frontline clinicians, epidemiologists, laboratory scientists, humanitarian workers, emergency responders, and public health leaders serving with courage, compassion, and commitment. 🌍🙏🏾☮️💜